NORML

FEBRUARY 1, 2019

Patients authorized to legally use medical cannabis frequently substitute it in place of benzodiazepines, according to a pair of new studies published this week. Full text of the study, “Reduction of benzodiazepine use in patients prescribed medical cannabis,” appears in the journal Cannabis and Cannabinoid Research here.

Patients 245

Patients Chronic Pain Therapy Data 245

Cannabis Law Report

MAY 19, 2022

.” Hartle, 54, is one of the very few Canadians to have received legal psychedelics psychotherapy for a mental health condition since Health Canada made it easier in January for health-care workers to access psilocybin — the hallucinogenic compound found in some mushrooms. ” Health Canada on Jan.

Therapy 52

Therapy Patients Treatment Clinical Trials 52

Cannabis Law Report

OCTOBER 4, 2021

Advanced Illness , Oregon Psilocybin Advisory Board , Oregon Psilocybin Services Act , Psilocybin , Psilocybin Therapy , Psychedelics , Right To Try. One of the known beneficial uses of psilocybin is as a palliative care tool for patients with advanced illness who suffer from anxiety and/or depression.

Therapy 52

Therapy Patients Law Clinical Trials 52

NORML

AUGUST 27, 2019

Legislation will take effect next week expanding protections for state-qualified medical cannabis patients. It strengthens patient protections by explicitly stipulating that registered cannabis consumers may not be denied public assistance, access to firearms, or certain types of employment solely based upon their patient status.

Patients 195

Patients Therapy Banking Access 195

Cannabis Law Report

MAY 19, 2022

This is Numinus’ first psilocybin-assisted therapy treatment outside of ongoing clinical trials, and among the first to use of this regulatory mechanism through Health Canada’s Special Access Program (“SAP”), which was amended January 5 th , 2022 to include access to psychedelic compounds on a case-by-case basis.

Therapy 52

Therapy Treatment Clinical Trials Access 52

MMJ Recs

MARCH 28, 2024

Navigating the world of medical marijuana (MMJ) in Iowa can be a daunting task for patients seeking alternative treatments. From researching qualified doctors to scheduling appointments and discussing treatment options, we provide practical insights and tips to help patients confidently navigate this journey.

Patients 52

Patients Treatment Research and Development Therapy 52

Cannabis Law Report

AUGUST 3, 2022

Eight Canadians have filed a Charter challenge against the Government of Canada and the Minister of Health regarding patient access to psilocybin and psilocybin therapy. The Patients / Plaintiffs. This is the landmark case that is going to legalize psychedelics in Canada,” says TheraPsil’s CEO Spencer Hawkswell.

Access 52

Access Patients Therapy Legalization 52

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

JANUARY 6, 2022

CNSX : FTRP; OTCMKTS : FTRPF), a global leader in the development and delivery of psychedelic therapies, today announced that it will begin making applications for Canadians in need to access psilocybin-assisted and MDMA-assisted therapy through Health Canada’s Special Access Program (SAP). Field Trip Health Ltd.

Access 52

Access Patients Therapy Conditions 52

NORML

FEBRUARY 13, 2019

Today, Senator Brian Schatz (D-HI) and Representative Barbara Lee (D-CA) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act , to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions.

Legislation 235

Legislation Access Chronic Pain Marijuana 235

NORML

NOVEMBER 8, 2019

This year, we can and must succeed in passing this essential legislation and protecting the rights of veterans to access medical treatment and serving those who served us. Research published in the Journal of Psychoactive Drugs found a 75% reduction in Clinician-Administered Posttraumatic Scale scores following cannabis therapy.

Access 212

Access Marijuana Treatment Legislation 212

Cannabis Law Report

MARCH 22, 2023

When psychedelic therapies begin to gain regulatory approval, they will need to be incorporated into the medical billing and coding system in a way that ensures equitable patient access, say experts.

Therapy 52

Therapy Treatment Conditions Access 52

Cannabis Law Report

JANUARY 6, 2022

This blog post will explain how psilocybin patenting and other factors could make Oregon’s psilocybin program prohibitively expensive for low-income patients, and how big pharma is maneuvering to monopolize psychedelic therapy. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products.

Access 52

Access Patients Research and Development Treatment 52

NORML

NOVEMBER 25, 2019

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One.

Chronic Pain 282

Chronic Pain Patients Therapy Data 282

Cannabis Law Report

DECEMBER 5, 2021

Revenue share payments will be based on North America sales of MDMA for use in MDMA-assisted therapy, will terminate after 8 years, and include a reciprocity payment structure that reduces payments once certain financial milestones are met. The safety and efficacy of MDMA-assisted therapy is currently under investigation.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. This guide aims to demystify the process, offering practical advice and insights to help patients make informed decisions.

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

MMJ Recs

OCTOBER 9, 2023

As Texas residents seek alternative therapies for chronic pain and other debilitating conditions, it becomes crucial to navigate the world of MMJ pain management centers effectively. These centers differ in terms of services, expertise, and their approach to patient care. Top-Rated Medical Cannabis Clinics in Texas 1.

Chronic Pain 52

Chronic Pain Patients Treatment Conditions 52

Canna Law Blog

NOVEMBER 10, 2020

I was talking to another lawyer about last week’s vote by Oregonians to legalize psilocybin therapy here in the state. Public Law 115-176 (“Right to Try”) is a federal law enacted in 2018 that creates a uniform system for terminal patients seeking access to investigational treatments. It’s quite restrictive.

Therapy 78

Therapy Clinical Trials Decriminalization Patients 78

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.

Patients 98

Patients Education Marijuana Therapy 98

Veriheal

MAY 26, 2022

Patients around the world are in need of natural, alternative medical solutions, and Realm of Caring (RoC) is on a mission to serve them. Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy.

Advocacy 96

Advocacy Patients Clinical Trials Education 96

Veriheal

JANUARY 18, 2024

Cannabis nurses are crucial in bridging the gap between traditional healthcare and emerging cannabis therapies. Patient education is their primary focus, as they provide knowledgeable guidance on the therapeutic benefits and potential risks of cannabis. They also seamlessly integrate this knowledge into everyday patient care.

Education 113

Education Therapy Patients Research and Development 113

Veriheal

JUNE 7, 2021

Note: Veriheal does not support illegally consuming therapeutic substances like MDMA but acknowledges that it transpires because of the current illicit status of both, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.

Therapy 67

Therapy Treatment Conditions Clinical Trials 67

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. About Curaleaf International.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

AUGUST 19, 2021

Cannim will sell its products in the EU medical markets through the Cantourage Fast Track Access Platform. The agreement allows medical cannabis flowers from Jamaica to be made available to German patients for the first time. Cantourage continues to provide innovative cultivars and a safe, diverse supply for patients”.

Access 98

Access Cultivation Patients Indica 98

MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Patients must first schedule an appointment with a licensed medical professional who can evaluate their medical history and condition. In 1996, the state became the first in the U.S.

Dispensary 52

Dispensary Patients Environment Conditions 52

MMJ Recs

JANUARY 16, 2023

Read on to discover some of the best pain management centers in West Virginia that MMJ patients should know about. Pain management doctors in West Virginia use a wide range of treatments to manage chronic pain and provide patients with an improved quality of life. Physical therapy. Medical Marijuana For Chronic Pain.

Chronic Pain 98

Chronic Pain Patients Treatment Medicine 98

MMJ Recs

FEBRUARY 27, 2024

As the state continues to navigate the complexities of legalization, patients, dispensaries, and the cannabis industry are witnessing significant changes. Dispensaries serve as the primary access point for patients seeking medical marijuana products. Medications, physical therapy, and, in some cases, surgery may be recommended.

Dispensary 93

Dispensary Legalization Marijuana Therapy 93

Veriheal

FEBRUARY 18, 2021

But it’s acknowledged that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. The university has conducted research that studied the best music to include in psychedelic therapy. What is Psychedelic Therapy.

Therapy 52

Therapy Research and Development Collective Consumption 52

NORML

MAY 27, 2020

Senators on Wednesday passed legislation to significantly expand the pool of patients eligible to qualify for medical cannabis access. ” Under the current law , doctors may only recommend medical cannabis products to those patients with a limited number of select conditions, such as HIV and cancer. .”

Conditions 280

Conditions Legislation Therapy Patients 280

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has the potential to reduce opioid dependence and addiction, leading to safer and healthier communities.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

MMJ Recs

APRIL 5, 2024

With cancer care, New York has emerged as a beacon of progress, offering patients access to a holistic approach that includes medical marijuana. By harnessing the therapeutic properties of cannabis, patients can experience symptom relief and improved quality of life throughout their cancer journey.

Treatment 52

Treatment Marijuana Patients Therapy 52

United Patients Group

NOVEMBER 21, 2023

Traditional treatments with prescription medications can sometimes be insufficient or accompanied by undesirable side effects, leaving patients in search of alternative methods for pain relief. Harlequin is ideal for patients seeking clear-headed pain relief during daytime hours.

Chronic Pain 80

Chronic Pain Strains Patients Marijuana 80

Cannabis Law Report

DECEMBER 15, 2021

Another three patients who have petitioned the federal government to use psilocybin therapy as a treatment for their mental health conditions have received an exemption from the minister of health to legally undergo this therapy. . based non-profit TheraPsil, was one of the patients granted an exemption.

Patients 52

Patients Therapy Conditions Access 52

MMJ Recs

SEPTEMBER 19, 2023

These clinics offer a wide range of services to address chronic pain, including advanced procedures and therapies. Patients in Kansas City (as well as the wider Missouri area) have access to top-tier pain management specialists who are dedicated to improving their quality of life.

Chronic Pain 52

Chronic Pain Patients Treatment Therapy 52

MMJ Recs

NOVEMBER 21, 2022

MMJRecs offers a quick and convenient renewal process so that you can continue to access the MMJ products you require for your medical condition. With multiple branches throughout Arkansas as well as elsewhere, the doctors here have a simple goal at the front of their mind: “Put our patients back in control of their lives”.

Chronic Pain 52

Chronic Pain Patients Wellness and Beauty Treatment 52

Cannabis Law Report

JUNE 14, 2022

PAREA is a non-profit, multistakeholder and multidisciplinary partnership bringing together patient organizations, medical associations, scientific societies, psychedelic foundations, and the for-profit sector. The good news is that innovations that completely change the lives of patients continue to emerge.

Access 52

Access Therapy Clinical Trials Treatment 52